This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Monocytic leukaemia
CD2_MONOCYTIC_LEUKAEMIA
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
111 |
4. Check minimum number of eventsNone |
111 |
5. Include endpointsNone |
111 |
6. Filter based on genotype QC (FinnGen only) |
111 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF8
- Parent code in ICD-10
- C81-C96
- Name in latin
- Leuc(h)aemia monocytica
Similar endpoints
↥List of similar endpoints to
Monocytic leukaemia
based on the number of shared cases.
Similar with more cases:
- Monocytic leukaemia
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 111 | 47 | 64 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.03 |
| Median age at first event (years) | 65.71 | 60.56 | 69.49 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 101
- Matched controls
- 1008
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
+∞
46.5
41
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
53.0
46.1
55
22
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
+∞
36.7
33
*
XW000
NOMESCO Finland
Bone marrow biopsy
44.3
32.0
39
14
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
+∞
25.0
23
*
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
+∞
21.6
20
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
246.1
20.3
20
*
WW500
NOMESCO Finland
Blood transfusion
22.0
19.8
29
18
D64.9
ICD-10 Finland
Anaemia, unspecified
7.2
13.2
35
69
R50.9
ICD-10 Finland
Fever, unspecified
6.3
12.0
35
78
C93.9
ICD-10 Finland
Monocytic leukaemia, unspecified
+∞
11.7
11
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.9
11.4
30
58
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
6.0
10.5
31
69
A04AA01
ATC
ondansetron; systemic, rectal
7.5
9.3
22
36
Z51.5
ICD-10 Finland
Palliative care
7.7
9.1
21
33
M04AA01
ATC
allopurinol; systemic
4.6
9.1
35
104
L01XX05
ATC
hydroxycarbamide; oral
30.5
8.7
11
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
12.3
8.6
15
14
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
+∞
8.4
8
*
9860/3-C42.1
ICD-O-3
Myeloid leukemia, NOS, of bone marrow
+∞
8.4
8
*
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
+∞
8.4
8
*
L03AA02
ATC
filgrastim; parenteral
19.2
8.3
12
7
J05AB11
ATC
valaciclovir; oral
4.6
7.1
25
67
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
74.3
6.5
7
*
A41.9
ICD-10 Finland
Sepsis, unspecified
8.6
6.3
13
17
A05AA02
ATC
ursodeoxycholic acid; oral
28.6
6.3
8
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
28.6
6.3
8
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
6.3
6
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
6.3
6
*
B03XA02
ATC
darbepoetin alfa; parenteral
11.0
6.2
11
11
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.9
6.0
12
15
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
27
32
10.83
22.00
6.0
2.1
—
—
—
0
0
41
153
3.66
9.32
7.4
3.5
0.8
0.8
mmol/l
0.05
41
141
14
21
7.48
9.13
3.2
2.0
—
—
—
0
0
16
29
6.28
8.78
3.2
1.8
—
—
—
0
0
16
30
6.06
8.49
3.0
1.8
—
—
—
0
0
8
0
+∞
8.43
1.0
0.0
—
—
—
0
0
14
29
5.38
6.65
1.4
1.4
—
—
—
0
0
10
7
15.52
6.53
4.0
2.7
—
—
—
0
0
12
22
5.99
6.44
1.8
1.4
—
—
—
0
0
14
32
4.86
5.96
1.6
1.4
—
—
—
0
0
10
9
12.06
5.92
2.5
2.7
—
—
—
0
0
10
9
12.06
5.92
2.5
2.7
—
—
—
0
0
13
30
4.78
5.46
3.0
2.0
175.7
199.6
%
0.47
13
30
5
0
+∞
5.24
1.0
0.0
—
—
—
0
0
10
19
5.69
5.14
2.6
1.8
—
—
—
0
0
9
9
10.75
5.13
1.7
1.2
—
—
—
0
0
21
73
3.31
5.10
2.9
1.6
—
—
—
0
0
9
12
8.05
4.45
17.9
5.3
—
—
—
0
0
8
9
9.46
4.35
2.1
2.9
—
—
—
0
0
24
102
2.73
4.09
4.2
5.3
5.7
5.8
kpa
0.17
24
97
11
28
4.25
4.08
1.4
1.5
0.1
0.0
iu/ml
—
6
5
14
43
3.58
4.06
3.4
1.4
—
—
—
0
0
33
166
2.41
3.99
3.9
2.0
—
—
—
0
0
40
220
2.28
3.94
16.7
2.4
—
—
—
0
0
18
67
3.01
3.88
1.7
1.4
—
—
—
0
0
8
13
6.53
3.57
1.3
1.7
—
—
—
0
0
6
6
10.47
3.54
5.7
2.2
—
—
—
0
0
6
6
10.47
3.54
5.7
2.3
—
—
—
0
0
6
6
10.47
3.54
5.7
2.2
—
—
—
0
0
6
6
10.47
3.54
5.7
2.3
—
—
—
0
0
6
6
10.47
3.54
5.7
2.3
—
—
—
0
0
6
6
10.47
3.54
5.7
2.3
—
—
—
0
0
6
6
10.47
3.54
5.7
2.2
—
—
—
0
0
12
37
3.52
3.45
3.8
1.5
0.1
0.2
g/l
0.28
12
31
25
118
2.44
3.43
2.8
1.8
—
—
—
0
0
7
10
7.38
3.41
1.9
1.1
—
—
—
0
0
25
122
2.35
3.18
2.7
1.9
—
—
—
0
0
7
12
6.14
3.07
5.1
2.3
—
—
—
0
0
7
12
6.14
3.07
5.1
2.3
—
—
—
0
0
7
12
6.14
3.07
5.1
2.3
—
—
—
0
0
11
36
3.28
2.90
4.0
1.4
34.9
36.8
g/l
0.41
11
30
61
433
1.91
2.81
25.6
4.4
—
—
—
0
0
5
6
8.65
2.77
1.4
1.3
—
—
—
0
0
7
14
5.26
2.77
1.7
1.3
—
—
—
0
0
8
19
4.45
2.73
2.0
1.3
—
—
—
0
0
6
10
6.27
2.73
3.3
2.3
—
—
—
0
0
6
10
6.27
2.73
3.3
2.3
—
—
—
0
0
6
10
6.27
2.73
3.3
2.3
—
—
—
0
0
6
10
6.27
2.73
3.3
2.3
—
—
—
0
0
7
15
4.90
2.64
5.1
2.1
—
—
—
0
0
65
478
1.87
2.61
16.4
6.9
1.2
1.2
mmol/l
0.82
58
395
71
857
0.52
2.57
4.8
4.6
1.2
1.4
mmol/l
3.31
64
759
7
16
4.59
2.52
1.7
1.3
—
—
—
0
0
8
21
4.02
2.51
1.9
1.4
—
—
—
0
0
72
863
0.53
2.48
5.1
4.6
4.1
4.4
mmol/l
1.54
66
773
75
887
0.52
2.44
5.4
5.1
2.4
2.6
mmol/l
0.84
68
787
7
17
4.32
2.40
1.1
1.1
—
—
—
0
0
59
429
1.80
2.39
14.7
6.1
1.2
1.2
mmol/l
0.50
59
381
18
87
2.28
2.32
1.3
2.6
0.2
0.2
g/l
0.03
18
77
51
359
1.78
2.28
5.9
3.2
—
—
—
0
0
69
830
0.55
2.24
4.9
4.2
1.5
1.3
mmol/l
1.25
63
731
8
24
3.51
2.23
1.9
1.4
—
—
—
0
0
8
24
3.51
2.23
1.9
1.4
—
—
—
0
0
6
14
4.46
2.18
5.7
2.2
—
—
—
0
0
5
10
5.18
2.09
1.0
1.1
—
—
—
0
0
44
305
1.73
2.02
4.0
3.1
49.9
32.9
u/l
0.36
44
291
6
16
3.90
1.96
1.5
1.9
—
—
—
0
0
5
11
4.70
1.96
3.8
2.2
—
—
—
0
0
5
11
4.70
1.96
3.8
2.2
—
—
—
0
0
6
17
3.67
1.86
14.7
2.2
52.0
62.6
%
—
6
17
9
35
2.71
1.85
6.7
2.1
—
—
—
0
0
7
23
3.18
1.83
1.4
1.8
—
—
—
0
0
15
76
2.13
1.74
6.9
3.0
4.8
5.0
kpa
0.32
15
68
6
19
3.28
1.68
1.5
1.7
—
—
—
0
0
10
43
2.46
1.65
9.2
3.8
24.4
25.7
mmol/l
—
10
43
24
147
1.81
1.65
4.9
3.0
0.8
1.9
e6/l
0.62
17
91
8
32
2.61
1.63
1.6
1.4
—
—
—
0
0
6
20
3.11
1.60
1.5
1.8
—
—
—
0
0
6
21
2.96
1.52
1.2
1.1
—
—
—
0
0
25
160
1.73
1.48
4.5
2.8
1.3
0.8
e6/l
0.21
18
102
9
40
2.36
1.44
3.2
2.9
—
—
—
0
0
26
172
1.67
1.37
1.2
1.3
1.1
1.4
u/ml
—
9
51
85
937
0.60
1.34
52.1
19.7
92.7
81.9
umol/l
1.65
85
937
11
55
2.11
1.32
3.0
1.7
—
—
—
0
0
5
18
2.86
1.30
1.0
1.5
—
—
—
0
0
17
103
1.77
1.21
6.4
3.7
—
—
—
0
0
5
21
2.44
1.10
1.2
1.9
—
—
—
0
0
7
33
2.19
1.07
3.3
1.8
—
—
—
0
0
11
60
1.93
1.07
7.5
3.5
0.0
0.1
e6/l
1.77
11
60
9
47
1.99
1.05
1.9
6.0
2.0
1.2
%
—
9
47
74
827
0.68
1.03
6.5
6.3
40.8
40.9
mmol/mol
0.02
67
754
36
280
1.42
0.91
5.1
3.0
0.8
0.4
e6/l
0.51
31
223
76
838
0.70
0.88
38.2
16.1
69.2
76.3
ml/min/173m2
1.39
66
680
79
865
0.70
0.88
5.8
5.0
6.4
6.1
mmol/l
0.70
74
768
53
445
1.37
0.84
6.1
4.1
0.0
0.0
estimate
0.00
12
77
52
436
1.36
0.83
7.5
5.4
0.0
0.0
estimate
0.00
12
83
52
437
1.36
0.82
6.3
4.1
0.0
0.0
estimate
0.00
11
86
47
391
1.35
0.78
3.9
4.5
37.5
50.5
ng/l
0.35
35
295
5
24
2.13
0.75
4.6
5.8
50.0
36.1
mg/l
—
5
17
47
393
1.34
0.75
2.9
2.0
83.9
91.8
pmol/l
0.65
30
200
14
97
1.51
0.62
6.5
7.0
1.3
1.3
mmol/l
0.05
14
91
6
40
1.53
0.52
1.5
1.3
—
—
—
0
0
31
258
1.28
0.49
8.0
4.5
0.0
0.0
estimate
—
9
77
18
141
1.33
0.43
5.8
5.6
11.1
11.4
kpa
0.10
18
133
18
141
1.33
0.43
5.8
5.7
4.9
5.0
kpa
0.18
18
132
5
31
1.64
0.43
1.2
1.2
—
—
—
0
0
5
31
1.64
0.43
1.2
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
7.0
—
0
5
40
350
1.22
0.41
7.1
4.5
—
—
—
0
0
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
71
659
1.21
0.40
5.5
3.8
14.8
14.9
pmol/l
0.13
66
581
6
43
1.42
0.35
15.0
3.6
4.6
4.4
pmol/l
—
6
38
15
126
1.22
0.22
1.4
1.3
1.2
13.5
u/ml
—
5
44
16
136
1.21
0.21
1.4
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
15.8
—
0
13
0
13
0.00
0.21
0.0
1.5
—
4.6
—
0
7
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
6
75
0.79
0.16
3.2
2.2
8.7
14.3
nmol/l
—
6
68
48
456
1.09
0.13
3.4
3.0
—
—
—
0
0
16
143
1.14
0.12
6.1
5.7
1.8
1.2
mmol/l
0.19
11
116
5
48
1.04
0.09
1.0
3.7
13.0
230.6
u/ml
—
5
41
87
886
0.92
0.09
50.0
17.0
30.2
25.7
mg/l
0.69
80
721
33
313
1.08
0.09
4.0
5.2
25.9
21.0
%
0.73
17
152
10
92
1.10
0.03
2.5
1.7
1.6
1.6
%
—
10
77
10
93
1.08
0.02
2.0
1.3
—
—
—
0
0
11
116
0.94
0.01
10.7
8.7
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.8
—
11.2
—
0
6
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
100.0
—
0
5
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.6
—
72.8
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
96.6
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_MONOCYTIC_LEUKAEMIA – Monocytic leukaemia
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).